Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Hypoxia-Inducible Transcription Factor 1 (HIF-1)in Vascular Aging

Authors not listed

Brigham and Women's Hospital · 2008

Abstract

The purpose of this study is determine if the iron chelator, desferrioxamine can increase blood levels of hypoxia-inducible transcription factor 1 (HIF-1 protein) and to see if there is a corresponding increase in blood flow to the brain.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-10-31 MST

Cite this

APA
Anonymous. (2008). Hypoxia-Inducible Transcription Factor 1 (HIF-1)in Vascular Aging. <em>Brigham and Women's Hospital</em>. https://clinicaltrials.gov/study/NCT01365104
Vancouver
Anonymous. Hypoxia-Inducible Transcription Factor 1 (HIF-1)in Vascular Aging. Brigham and Women's Hospital. 2008.
BibTeX
@misc{anon2008Hypoxi, title = {Hypoxia-Inducible Transcription Factor 1 (HIF-1)in Vascular Aging}, author = {Anonymous}, journal = {Brigham and Women's Hospital}, year = {2008}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings